The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
There were no significant differences in adherence and viral suppression rates between people in relationships and those who are single in Brazil, but the type of regime and pill quantities predict better outcomes.
The number of people living with HIV experiencing more than one non-communicable disease (NCD) increased as they got older, with metabolic diseases being the biggest contributor.
New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions.
A new low-cost, low-tech method for predicting an adult’s risk of developing tuberculosis (TB) could represent a major step forward for TB prevention.
Peru is the latest country to approve the use of the antiretroviral drug, Truvada, as pre-exposure prohpylaxis (PrEP) to prevent HIV among people at a high risk of infection.